Results 181 to 190 of about 210,681 (329)

Renal denervation in patients who do not respond to cardiac resynchronization therapy [PDF]

open access: bronze, 2022
Päivi Pietilä‐Effati   +6 more
openalex   +1 more source

Paced left ventricular QRS width and ECG parameters predict outcomes after cardiac resynchronization therapy: PROSPECT-ECG substudy.

open access: yes, 2011
International audienceBACKGROUND: For patients with symptomatic New York Heart Association class III or IV, ejection fraction ≤ 35%, and QRS ≥ 130 ms, cardiac resynchronization therapy (CRT) has become an established treatment option.
Hsing, Jeff M   +7 more
core   +2 more sources

Atrial Tram Tracks and Ventricular Step Ladder: Decoding the Dot Plot

open access: yesJournal of Arrhythmia, Volume 42, Issue 1, February 2026.
Falsely detected atrial tachycardia episode in a patient with CRT‐P due to FFRW oversensing resulting in ventricular sensed response triggered BiV pacing and auto adjusting sensitivity phenomenon.
Ramanathan Velayutham   +3 more
wiley   +1 more source

136-48: Unfavourable outcome after the upgrade of an implantable cardioverter defibrillator to cardiac resynchronization therapy [PDF]

open access: bronze, 2016
Alexandra Kiss   +4 more
openalex   +1 more source

Conduction System Pacing Versus Conventional Cardiac Resynchronization Therapy in Congenital Heart Disease [PDF]

open access: green, 2022
Jeremy P. Moore   +21 more
openalex   +1 more source

16-75: Clinical outcomes and QRS duration change in the late responders of cardiac resynchronization therapy [PDF]

open access: bronze, 2016
Young Choi   +13 more
openalex   +1 more source

European Cardiac Resynchronization Therapy Survey II: rationale and design [PDF]

open access: yes, 2015
The Cardiac Resynchronization Therapy (CRT) Survey II is a 6 months snapshot survey initiated by two ESC Associations, the European Heart Rhythm Association and the Heart Failure Association, which is designed to describe clinical practice regarding ...
Dickstein, Kenneth   +15 more
core  

Sodium glucose co‐transporter 2 inhibitors versus dipeptidyl peptidase‐4 inhibitors and the risk of ventricular arrhythmia among patients with type 2 diabetes: A population‐based cohort study

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 935-945, February 2026.
Abstract Aims To determine whether sodium glucose co‐transporter 2 inhibitors (SGLT2i) use, compared with dipeptidyl peptidase‐4 inhibitors (DPP4i) use, is associated with the risk of ventricular arrhythmias (VA) among patients with type 2 diabetes. Materials and Methods We conducted a population‐based cohort study using a prevalent new‐user design and
Wang‐Choi Tang   +5 more
wiley   +1 more source

56-71: Long-term Cardiac Resynchronization Therapy Reduces T-wave Alternans in Patients with Cardiomyopathy [PDF]

open access: bronze, 2016
Sachin Nayyar   +5 more
openalex   +1 more source

Home - About - Disclaimer - Privacy